---
layout: spectre
title: Metrics
permalink: /spectre/metrics/
---

## Spectre publications

- v0: Ashhurst et al, 2019, [Mass Cytometry: Methods and Protocols](https://doi.org/10.1002/cyto.a.24350) (referred to at the time as 'CAPX')
- v1: Ashhurst et al, 2021, [Cytometry A](https://link.springer.com/protocol/10.1007/978-1-4939-9454-0_12)

<p> </p>

## User stats

Since the launch of our hosting website in March 2021, the software and associated protocols have attracted >4700 unique users (as of August 2022), averaging 330 new users per month from across the world, including Australia (25.7%), United States (26.6%), Germany (11.08%), United Kingdom (5.1%), China (4.44%), among others.

<p> </p>

## Works citing Spectre

Our software and associated analysis protocols have been cited in at least 44 publications since 2018, both with our team and independently, in prestigious journals such as [Cell](https://doi.org/10.1016/j.cell.2018.08.013), [Nature Immunology](https://www.researchgate.net/publication/343838774_The_NK_cell_granule_protein_NKG7_regulates_cytotoxic_granule_exocytosis_and_inflammation), and [Blood](https://ashpublications.org/blood/article/138/Supplement%201/2168/478408). It is also a featured analysis package for the [Human Cell Atlas](https://data.humancellatlas.org/analyze/methods/spectre) project. Spectre has been used in the study of 
[COVID-19](https://www.sciencedirect.com/science/article/pii/S2666379121000197) pathogenesis, 
[vaccine](https://www.nature.com/articles/s41385-021-00379-6) responses, 
[NK cell](https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006999) biology, 
[multiple myeloma](https://ashpublications.org/bloodadvances/article/4/19/4593/463891/Inverse-relationship-between-oligoclonal-expanded), 
[pediatric burns](https://www.frontiersin.org/articles/10.3389/fimmu.2020.01481/full), 
[multiple sclerosis](https://onlinelibrary.wiley.com/doi/full/10.1002/cti2.1133), 
[bone marrow](https://www.frontiersin.org/articles/10.3389/fimmu.2018.01672/full) transplantation, and 
[cerebral malaria](https://www.nature.com/articles/s42003-018-0216-2), 
among others.

*Cited in pre-prints*

- Ryan FJ et al, 2022, [medRxiv](https://www.medrxiv.org/content/10.1101/2022.09.22.22280180v1).
- Ashhurst A et al, 2022, [Research Square](https://assets.researchsquare.com/files/rs-1179181/v1/6c963fd7-b135-468c-83a3-39502e135591.pdf?c=1641417736) (pre-print)

*Cited in research*

- León-Lara et al, 2022, [Frontiers in Immunology](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891705/)
- Baker et al, 2022, [USYD](https://ses.library.usyd.edu.au/handle/2123/29173)
- Teo et al, 2022, [bioRxiv](https://www.biorxiv.org/content/10.1101/2022.05.29.493337v2.abstract)
- Souza-Fonseca-Guimaraes et al, 2022, [Cancer Immunology](https://aacrjournals.org/cancerimmunolres/article-abstract/doi/10.1158/2326-6066.CIR-21-1052/707295)
- Bartolo et al, 2022, [Science Immunology](https://www.science.org/doi/full/10.1126/sciimmunol.abn3127)
- Verstegen et al, 2022, [eLife](https://elifesciences.org/articles/77969)
- Putri et al, 2022, [Cytometry A](https://onlinelibrary.wiley.com/doi/abs/10.1002/cyto.a.24668)
- Zhang et al, 2022, [Nature Communications](https://www.nature.com/articles/s41467-022-30088-y)
- West et al, 2022, [Journal of Neuroinflammation](https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-022-02441-x)
- Marsh-Wakefield et al, 2022, [Immunology and Cell Biology](https://doi.org/10.1111/imcb.12552)
- Chedid et al, 2022, [Frontiers in Immunology](https://europepmc.org/articles/pmc8980213/bin/datasheet_1.docx)
- León-Lara et al, 2022, [Frontiers in Immunology](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891705/)
- Spiteri et al, 2022, [Frontiers in Immunology](https://www.researchgate.net/profile/Alanna-Spiteri/publication/359507023_PLX5622_Reduces_Disease_Severity_in_Lethal_CNS_Infection_by_Off-Target_Inhibition_of_Peripheral_Inflammatory_Monocyte_Production/links/6241542f7931cc7ccfff48a8/PLX5622-Reduces-Disease-Severity-in-Lethal-CNS-Infection-by-Off-Target-Inhibition-of-Peripheral-Inflammatory-Monocyte-Production.pdf)
- Liechti et al, 2021, [Nature Immunology](https://www.nature.com/articles/s41590-021-01006-z)
- Vick et al, 2021, [Science Advances](https://www.medrxiv.org/content/10.1101/2021.03.25.21254376v1)
- Spiteri et al, 2021, [Journal of Neuroinflammation](https://www.researchsquare.com/article/rs-388801/v1)
- Koutsakos et al 2021, [Cell Reports Medicine](https://www.sciencedirect.com/science/article/pii/S2666379121000197)
- Ferrell et al 2021, [Mucosal Immunology](https://www.nature.com/articles/s41385-021-00379-6)
- Putri et al 2021, [Bioinformatics](https://doi.org/10.1093/bioinformatics/btab038)
- Ng et al 2020, [Nature Immunology](https://www.nature.com/articles/s41590-020-0758-6)
- Vuckovic et al 2020, [Blood Advances](https://ashpublications.org/bloodadvances/article/4/19/4593/463891/Inverse-relationship-between-oligoclonal-expanded)
- Johnson et al 2020, [Frontiers in Immunology](https://www.frontiersin.org/articles/10.3389/fimmu.2020.01481/full)
- Ferrer-Font et al, 2020, [Cytometry Part A](https://onlinelibrary.wiley.com/doi/abs/10.1002/cyto.a.24016)
- Marsh-Wakefield et al 2020, [Clinical and Translational Immunology](https://onlinelibrary.wiley.com/doi/full/10.1002/cti2.1133)
- Pirozyan 2020, [Fronteirs in Immunology](https://www.frontiersin.org/articles/10.3389/fimmu.2020.00372/full)
- Counoupas et al 2020, [BioRxiv](https://doi.org/10.1101/2020.02.25.964312)
- Shinko et al 2019, [Frontiers in Immunology](https://www.frontiersin.org/articles/10.3389/fimmu.2019.02584/full)
- Hayashida et al 2019, [J Neuroinflam](https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1566-5)
- Marsh-Wakefield et al 2019, [Frontiers in immunology](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688400/)
- Stifter et al 2019, [Cell Reports](https://www.cell.com/cell-reports/pdf/S2211-1247(19)31492-5.pdf)
- Stern et al 2018, [Frontiers in Immunology](https://www.frontiersin.org/articles/10.3389/fimmu.2018.01672/full)
- McGuire et al 2018, [Cancer Immunology](https://link.springer.com/article/10.1007/s00262-017-2107-7)
- Campbell et al 2018, [Plos Pathogens](https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006999)
- Jung et al 2018, [J Immunol](https://www.jimmunol.org/content/201/7/2176.abstract)
- Roediger et al 2018, [Cell](https://doi.org/10.1016/j.cell.2018.08.013)
- Niewold et al 2018, [Communications Biology](https://www.nature.com/articles/s42003-018-0216-2)

*Cited in review*

- Marsh-Wakefield et al, 2022, [Therapeutic Advances in Medical Oncology](https://journals.sagepub.com/doi/full/10.1177/17588359221113270)
- Botta et al, 2022, [Blood Advances](https://ashpublications.org/bloodadvances/article/6/2/690/477072/FlowCT-for-the-analysis-of-large-immunophenotypic)
- Opzoomer et al, 2021, [eLife](https://elifesciences.org/articles/62915)
- Marsh-Wakefield et al, 2021, [Immunology and Cell Biology](https://onlinelibrary.wiley.com/doi/abs/10.1111/imcb.12456)
- Ye et al, 2021, [Blood](https://ashpublications.org/blood/article/138/Supplement%201/2168/478408) and [iScience](https://www.sciencedirect.com/science/article/pii/S2589004222004953)
- Spiteri et al 2020, [Frontiers in Immunology](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752943/)

<br />

From evidence at conferences, online posts, or feedback from users, we  know that these tools are in use in a wide range of contexts, including universities, research institutions, and biotechnology companies. These tools have also been referenced in a number of online forums and posts.

*Select presentations*

- Neurology 2020: [Alemtuzumab](https://n.neurology.org/content/94/15_Supplement/3937.abstract), [B cells and multiple sclerosis](https://n.neurology.org/content/94/15_Supplement/3953.abstract), [T cells and multiple sclerosis](https://n.neurology.org/content/94/15_Supplement/5301.abstract)
- [Cancer Research, 2019](https://cancerres.aacrjournals.org/content/79/13_Supplement/2307.short)
- [Annual Meeting of the German Society for Immunology, 2017](https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.201770300#page=243)
- [International Congress of Immunology, 2016](http://ici2016-c10000.epresenter.com.au/clients/1/121/submissions/14263/abstract.pdf)

*Online forums and posts*

- [ResearchGate](https://www.researchgate.net/post/What_are_the_best_R_packages_for_flow_cytometric_data_analysis): What are the best R packages for flow cytometric data analysis?
- [CyTOForum](http://cytoforum.stanford.edu/viewtopic.php?f=3&t=2007&p=5229&hilit=spectre#p5229): FlowJo transformation before clustering
- [CyTOForum](http://cytoforum.stanford.edu/viewtopic.php?f=3&t=2303&p=5729&hilit=spectre#p5729): Data representation
- [LinkedIn](https://www.linkedin.com/pulse/clinical-studies-immunotherapy-more-immune-monitoring-amir/): Clinical studies, immunotherapy, and more in the Immune Monitoring Biweekly (Issue 27)

Spectre has also featured prominently in community **workshops**, such as the '[high-dimensional analysis homeshow](https://immunedynamics.io/homeshow/)' in 2020, hosted by the [Australian Cytometry Society](https://cytometry.org.au/) and [Australia and New Zealand society for Immunology](https://www.immunology.org.au/).

<br />
